UBS Group »

Lyell Immunopharma shares owned by UBS Group

Quarter-by-quarter ownership of Lyell Immunopharma (LYEL) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Lyell Immunopharma

Tip: Access up to 7 years of quarterly data

All positions including Lyell Immunopharma held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lyell Immunopharma by UBS Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $406k 13k 30.78
2025-09-30 $345k 21k 16.24
2025-06-30 $227k 26k 8.84